LAPPANO, Rosamaria
 Distribuzione geografica
Continente #
NA - Nord America 6.620
EU - Europa 5.857
AS - Asia 4.862
SA - Sud America 1.305
AF - Africa 349
Continente sconosciuto - Info sul continente non disponibili 245
OC - Oceania 12
Totale 19.250
Nazione #
US - Stati Uniti d'America 6.377
RU - Federazione Russa 2.640
SG - Singapore 1.933
CN - Cina 946
BR - Brasile 925
VN - Vietnam 780
IT - Italia 755
UA - Ucraina 738
DE - Germania 513
AT - Austria 319
BD - Bangladesh 218
SE - Svezia 210
FR - Francia 182
SN - Senegal 166
HK - Hong Kong 165
FI - Finlandia 152
IN - India 146
AR - Argentina 134
TR - Turchia 124
CA - Canada 115
KR - Corea 113
GB - Regno Unito 91
ID - Indonesia 67
MX - Messico 65
NL - Olanda 63
EC - Ecuador 62
IQ - Iraq 59
CO - Colombia 53
ZA - Sudafrica 52
PK - Pakistan 46
BE - Belgio 34
VE - Venezuela 34
JP - Giappone 33
CZ - Repubblica Ceca 30
MA - Marocco 30
PL - Polonia 28
PY - Paraguay 28
CL - Cile 27
ES - Italia 25
SA - Arabia Saudita 24
PH - Filippine 22
UZ - Uzbekistan 21
DZ - Algeria 20
TN - Tunisia 18
AE - Emirati Arabi Uniti 17
MY - Malesia 17
UY - Uruguay 17
PE - Perù 16
KZ - Kazakistan 15
EG - Egitto 13
IE - Irlanda 13
KE - Kenya 13
AZ - Azerbaigian 12
CR - Costa Rica 12
NP - Nepal 12
AU - Australia 11
JM - Giamaica 11
IL - Israele 10
JO - Giordania 10
ET - Etiopia 9
OM - Oman 9
TH - Thailandia 9
AL - Albania 8
BO - Bolivia 8
EU - Europa 8
DO - Repubblica Dominicana 7
KH - Cambogia 7
HU - Ungheria 6
BG - Bulgaria 5
GE - Georgia 5
IR - Iran 5
KG - Kirghizistan 5
LB - Libano 5
MD - Moldavia 5
PA - Panama 5
RS - Serbia 5
AO - Angola 4
BH - Bahrain 4
BY - Bielorussia 4
CH - Svizzera 4
EE - Estonia 4
GA - Gabon 4
GT - Guatemala 4
HN - Honduras 4
LT - Lituania 4
ML - Mali 4
NG - Nigeria 4
NI - Nicaragua 4
QA - Qatar 4
RO - Romania 4
SV - El Salvador 4
CG - Congo 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
TT - Trinidad e Tobago 3
BW - Botswana 2
GD - Grenada 2
GR - Grecia 2
HR - Croazia 2
Totale 18.976
Città #
Moscow 2.601
Dallas 915
Singapore 790
Chandler 636
San Jose 507
Ashburn 394
Jacksonville 387
Council Bluffs 357
Boardman 294
Ho Chi Minh City 274
New York 271
San Mateo 269
Beijing 248
Vienna 232
Dearborn 202
Hanoi 186
Dakar 166
Hong Kong 153
Lauterbourg 113
Helsinki 112
Seoul 111
Rende 106
Lawrence 102
Shanghai 100
Roxbury 99
Munich 97
Los Angeles 93
São Paulo 91
Hefei 82
Izmir 78
Brooklyn 76
Santa Clara 71
Florence 68
Des Moines 66
Milan 56
Ann Arbor 47
Ottawa 42
Columbus 41
Rome 39
The Dalles 38
Haiphong 37
Seattle 37
Wilmington 35
Da Nang 32
Inglewood 32
Ogden 32
Brussels 31
San Francisco 30
Bremen 27
Tokyo 27
Brno 26
Biên Hòa 25
Turku 25
Frankfurt am Main 24
Guayaquil 24
Naples 24
Guangzhou 23
Orem 23
Baghdad 22
Chicago 22
Warsaw 22
Bari 21
Chennai 21
Cosenza 21
Toronto 21
Dhaka 20
Johannesburg 20
Rio de Janeiro 20
Amsterdam 19
Brasília 19
Tashkent 19
Tianjin 19
Houston 18
Jakarta 18
London 18
Mumbai 18
Buenos Aires 17
Catanzaro 17
Montevideo 17
Montreal 17
Buffalo 16
Cambridge 16
Mexico City 16
Pune 16
Quito 16
Lahore 15
Stockholm 15
Falkenstein 14
Istanbul 14
Ninh Bình 14
Redmond 14
Redwood City 14
Phoenix 13
Shenzhen 13
Arcavacata 12
Belo Horizonte 12
Bogotá 12
Dublin 12
Hải Dương 12
Omaha 12
Totale 11.828
Nome #
c-Jun activation is required for 4-hydroxytamoxifen-induced cell death in breast cancer cells 2.844
Computational Approaches for the Discovery of GPER Targeting Compounds 275
Crystallographic snapshots of host–guest interactions in drugs@metal–organic frameworks: towards mimicking molecular recognition processes 259
AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs) 239
(6-Bromo-1,4-dimethyl-9H-carbazol-3-yl-methylene)-hydrazine (Carbhydraz) Acts as a GPER Agonist in Breast Cancer Cells 237
Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells 237
Functional characterization of the partially purified Sac1p-independent adenine nucleotide transport system (ANTS) from yeast endoplasmic reticulum 225
A calixpyrrole derivative acts as an antagonist to GPER, a G-protein coupled receptor: mechanisms and models. 222
Copper activates HIF-1α/GPER/VEGF signalling in cancer cells 220
GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells Toward Breast Tumor Progression 212
GPER, IGF-IR, and EGFR transduction signaling are involved in stimulatory effects of zinc in breast cancer cells and cancer-associated fibroblasts 205
E-cadherin mediates the aggregation of breast cancer cells induced by tamoxifen and epidermal growth factor 202
A Biocompatible Aspartic-Decorated Metal-Organic Framework with Tubular Motif Degradable under Physiological Conditions 200
Bisphenol A Induces Gene Expression Changes and Proliferative Effects through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts 197
G protein-coupled estrogen receptor mediates the up-regulation of fatty acid synthase induced by 17β-estradiol in cancer cells and cancer-associated fibroblasts 195
Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells 190
miR-338-3p Is Regulated by Estrogens through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts (CAFs) 188
Carbazole derivatives as potential novel agonist of GPER 187
Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells 186
Focal Adhesion Kinase Fine Tunes Multifaced Signals toward Breast Cancer Progression 183
The lauric acid-activated signaling prompts apoptosis in cancer cells 178
Interleukin-1β mediates a tumor-supporting environment prompted by IGF1 in triple-negative breast cancer (TNBC) 177
Focal Adhesion Kinase (FAK)-Hippo/YAP transduction signaling mediates the stimulatory effects exerted by S100A8/A9-RAGE system in triple-negative breast cancer (TNBC) 171
Activation of the s100a7/rage pathway by igf-1 contributes to angiogenesis in breast cancer 171
DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop 168
Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targets 166
GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells 161
A sexually dimorphic distribution pattern of the novel estrogen receptor G-protein coupled receptor 30 in some brain areas of the hamster 160
The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells 159
A Bodipy as a luminescent probe for detection of the G protein estrogen receptor (GPER) 158
Composition, Antifungal and Antiproliferative Activities of the Hydrodistilled Oils from Leaves and Flower Heads of Pterocephalus nestorianus Nab. 156
G protein-coupled receptor 30 expression is up-regulated by EGF and TGFalpha in estrogen receptor alpha-positive cancer cells 156
In vitro antiproliferative and proapoptotic activities of 2-oxazolidinone derivatives 156
Estrogen receptor variant ERα46 and insulin receptor drive in primary breast cancer cells growth effects and interleukin 11 induction prompting the motility of cancer‐associated fibroblasts 156
Identification of novel estrogen-regulated microRNAs in breast tumor cells and cancer-associated fibroblasts (CAFS) 155
Estrogenic Gper-signaling triggers RERG expression in breast cancer cells and cancer-associated fibroblasts 154
IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells 154
The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis 152
Different 6-Aryl-Fulvenes exert anti-proliferative effects on Cancer Cells 149
G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells 149
Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells 148
A Review on the Antimicrobial Activity of Schiff Bases: Data Collection and Recent Studies 148
Effects of antidiabetic medications on the relationship between type 2 diabetes mellitus and cognitive impairment 147
Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients 146
The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancer 146
GPER mediates activation of HIF1α/VEGF signaling by estrogens 145
The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs) 145
SLC37A1 Gene expression is up-regulated by epidermal growth factor in breast cancer cells 143
HYPOXIA PROMOTES TUBULAR INJURY VIA THE ACTIVATION OF THE ESTROGENIC RECEPTOR GPER AND P75(NTR) 143
GPER deletion triggers inhibitory effects in triple negative breast cancer (TNBC) cells through the JNK/c-Jun/p53/Noxa transduction pathway 142
GPER is involved in the regulation of the estrogen-metabolizing CYP1B1 enzyme in breast cancer 141
SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer 140
The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells 140
HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs) 137
Recent Advances on the Role of G Protein-Coupled Receptors in Hypoxia-Mediated Signaling 135
Newly Synthesized Imino-Derivatives Analogues of Resveratrol Exert Inhibitory Effects in Breast Tumor Cells 135
Epidermal growth factor up-regulates SLC37A1 gene expression in cancer cells. 134
GPER signalling in both cancer-associated fibroblasts and breast cancer cells mediates a feedforward IL1β/IL1R1 response 133
A novel functional crosstalk between DDR1 and the IGF axis and its relevance for breast cancer 131
Effects of Atrazine on Estrogen Receptor α- and G Protein-Coupled Receptor 30-Mediated Signaling and Proliferation in Cancer Cells and Cancer-Associated Fibroblasts 129
The AGEs/RAGE Transduction Signaling Prompts IL-8/CXCR1/2-Mediated Interaction between Cancer-Associated Fibroblasts (CAFs) and Breast Cancer Cells 128
miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20/c-Rel/CTGF signaling 126
Glycerophospholipid synthesis as a novel drug target against cancer 125
MIBE acts as antagonist ligand of both estrogen receptor alpha and GPER in breast cancer cells 124
Cross-talk between GPER and growth factor signaling 121
Stimulatory actions of IGF-I are mediated by IGF-IR cross-talk with GPER and DDR1 in mesothelioma and lung cancer cells 119
Two Novel GPER Agonists Induce Gene Expression Changes and Growth Effects in Cancer Cells. 118
GPCR modulation in breast cancer 118
Ddr1 affects metabolic reprogramming in breast cancer cells by cross-talking to the insulin/igf system 117
GPCRs and cancer 116
The novel estrogen receptor, G protein-coupled receptor 30, mediates the proliferative effects induced by 17β-estradiol on mouse spermatogonial GC-1 cell line 115
Insulin-like growth factor-I regulates GPER expression and function in cancer cells 114
ESTROGENIC GPR30 SIGNALLING INDUCES PROLIFERATION AND MIGRATION OF BREAST CANCER CELLS THROUGH CTGF 114
Estetrol/GPER/SERPINB2 transduction signaling inhibits the motility of triple-negative breast cancer cells 113
Recent Advances in the Rationale Design of GPER Ligands. 111
Dissecting CYP1A2 Activation by Arylalkanoic Acid Prodrugs toward the Development of Anti-Inflammatory Agents 110
Multifactorial Regulation of GPER Expression in Cancer Cells and Cardiomyocytes 110
GPER is involved in the regulation of CYP1b1 expression in breast cancer cells and CAFs 108
Macromolecular Modelling and Docking Simulations for the Discovery of Selective GPER Ligands. 108
RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer 107
New titanocene derivatives with high antiproliferative activity against breast cancer cells 106
Niacin activates the G protein estrogen receptor (GPER)-mediated signalling 105
IGF-I/IGF-IR Transduction System Involves GPER and DDR1 in the Stimulation of Mesothelioma and Lung Cancer Cells 104
Tamoxifen and epidermal growth factor induce the aggregation of MCF7 breast cancer cells up-regulating E-cadherin expression 104
Identification of a human estrogen receptor α tetrapeptidic fragment with dual antiproliferative and anti-nociceptive action 103
GPER Function in Breast Cancer: An Overview 103
Structure-activity relationships of resveratrol and derivatives in breast cancer cells 103
The novel estrogen receptor GRP30 mediates the proliferatiive effects induced by 17beta-estradiol onGC-1 mouse spermatogonial cell line 102
RUOLO DEL RECETTORE p75NTR E DEL RECETTORE ESTROGENICO GPER NEL DANNO IPOSSICO TUBULARE 102
Regulation of SLC37A1 gene expression by epidermal growth factor in breast cancer cells 101
Novel Mechanisms Involved in the Stimulatory Effects Exerted by Zinc in Breast Cancer Cells 100
Harnessing sample preparation for RNA-sequencing toward a reliable bioinformatics analysis 97
The Physiopathological Role of the Exchangers Belonging to the SLC37 Family 97
Organo-Metallic Compounds: Novel Molecules in Cancer Therapy 96
Recent views of heavy metals as possible risk factors and potential preventive and therapeutic agents in prostate cancer 95
RUOLO DEL NUOVO RECETTORE ESTROGENICO GPER E DELL'ASSE NGF/TRKA/P75NTR NEL DANNO IPOSSICO TUBULARE RENALE 95
The Novel Estrogen Receptor GPR30 Mediates the Proliferative Effects Induced by 17beta-Estradiol on GC-1 Mouse Spermatogonial Cell Line 93
The dark matter in cancer immunology: beyond the visible- unveiling multiomics pathways to breakthrough therapies 90
New metallorganic complexes of groups 3 and 4 as anticancer agents: Possible alterative to cis-platin. 90
Interaction of the Anti-Proliferative GPER Inverse Agonist ERα17p with the Breast Cancer Cell Plasma Membrane: From Biophysics to Biology 90
Totale 17.215
Categoria #
all - tutte 91.774
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.774


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.069 0 0 12 85 135 31 14 306 16 16 166 288
2022/20231.703 211 218 76 232 178 139 9 242 172 45 115 66
2023/20242.407 153 69 80 30 55 367 432 426 99 200 162 334
2024/20253.441 554 509 355 318 113 135 119 181 382 146 241 388
2025/20267.771 818 319 1.263 583 1.178 522 760 492 582 543 338 373
2026/2027660 458 160 42 0 0 0 0 0 0 0 0 0
Totale 19.250